Anaphase-promoting complex or cyclosome (APC) is a ubiquitin ligase which speci®cally targets mitotic regulatory factors such as Pds1/Cut2 and cyclin B. Identi®cation of the subunits of multiprotein complex APC in several species revealed the highly conserved composition of APC from yeast to human. It has been reported, however, that vertebrate APC is composed of at least eight subunits, APC1 to APC8, while budding yeast APC is constituted of at least 12 components, Apc1 to Apc13. It has not yet been clearly understood whether additional components found in budding yeast, Apc9 to Apc13, are actually composed of mammalian APC. Here we isolated and characterized human APC10/Doc1, and found that APC10/Doc1 binds to APC core subunits throughout the cell cycle. Further, it was found that APC10/Doc1 is localized in centrosomes and mitotic spindles throughout mitosis, while it is also localized in kinetochores from prophase to anaphase and in midbody in telophase and cytokinesis. These results strongly support the notion that human APC10/Doc1 may be one of the APC core subunits rather than the transiently associated regulatory factor.
Introduction
Anaphase-promoting complex or cyclosome (APC) is a ubiquitin ligase which speci®cally targets the mitotic regulatory factors (King et al., 1995; Sudakin et al., 1995; Funabiki et al., 1996; Peters et al., 1996; Zachariae et al., 1998a; Yu et al., 1998) . The APC activity was found to be regulated by at least four distinct mechanisms; activation and inactivation by phosphorylation and dephosphorylation (Hershko et al., 1994; Lahav-Baratz et al., 1995; Sudakin et al., 1995; Yamashita et al., 1996; Ishii et al., 1996; Peters et al., 1996; Shirayama et al., 1998; Descombes and Nigg, 1998; Charles et al., 1998; Kotani et al., 1998 Kotani et al., , 1999 , activation by the binding of substrate-speci®c WDrepeat proteins, Cdc20/p55CDC/Fizzy and Cdh1/Hct1/ Fizzy-related (Visintin et al., 1997; Schwab et al., 1997; Kallio et al., 1998; Fang et al., 1998a,b; Kramer et al., 1998; Zachariae et al., 1998b; Lorca et al., 1998) , suppression of APC activity by the spindle assembly checkpoint through the Mad family and Bub family (He et al., 1997; Li et al., 1997; Gorbsky et al., 1998; Kim et al., 1998; Hwang et al., 1998; Fang et al., 1998b; Kallio et al., 1998) , and regulation by Bub2 and the RENT complex system (Visintin et al., 1998 (Visintin et al., , 1999 Fesquet et al., 1999; Fraschini et al., 1999; Alexandru et al., 1999; Shou et al., 1999) .
Identi®cation of the subunits of multiprotein complex APC in several species revealed its highly conserved composition from yeast to human (Peters et al., 1996; Zachariae et al., 1998a; Yu et al., 1998) . Vertebrate APC is composed of at least eight subunits, APC1/Tsg24, APC2, APC3/CDC27Hs, APC4, APC5, APC6/CDC16Hs, APC7 and APC8/CDC23Hs (Peters et al., 1996; Yu et al., 1998) . The APC of budding yeast is constituted of at least 12 components, Apc1, Rsi1/Apc2, Cdc27/Apc3, Apc4, Apc5, Cdc16/Apc6, Cdc23/Apc8, Apc9, Doc1/Apc10, Apc11, Cdc26/ Apc12 and Apc13 (Zachariae et al., 1996 (Zachariae et al., , 1998a . It has not yet been clearly established whether or not additional components found in budding yeast, Apc9 to Apc13, are actually composed of mammalian APC.
APC10/DOC1, which was originally isolated by the enrichment of a mitotic arrest mutant of budding yeast, was identi®ed as a gene encoding a component of cyclin proteolysis machinery (Irniger et al., 1995; Hwang and Murray, 1997) . The doc1 mutants were arrested as large budded cells at 378C with a single nucleus and a short spindle, which were typical phenotypes in mitotic cyclin proteolysis mutants and showed a defect in the ubiquitination of mitotic cyclin in G1-arrested cells (Hwang and Murray, 1997) . Indeed, identi®cation of budding yeast APC subunits revealed that Doc1 is one of the APC components (Zachariae et al., 1998a) . Fission yeast apc10 mutant was isolated as a G1 arrest mutant which showed sterility and temperature-sensitive growth with a defect in chromosome segregation (Kominami et al., 1998) . The apc10+ was essential for cell viability, and the mutant showed two kinds of terminal morphology, elongated cells and cut phenotypes (Kominami et al., 1998) . It was found that Apc10 genetically and physically interacts with a universal subunit of the APC, and is required for the ubiquitination of B type cyclin (Kominami et al., 1998) . These results suggest that Apc10/Doc1 is crucial for mitotic exit and for the degradation of mitotic cyclins; however, it was demonstrated that Apc10/Doc1 may not be a core component of APC. The majority but not all Doc1 population co-sedimented at 20S APC in a sucrose gradient in budding yeast (Hwang and Murray, 1997) . In ®ssion yeast, myc-tagged Apc10 was not cosedimented with APC, and the sedimentation pro®les of APC components appear normal in apc10 mutant (Kominami et al., 1998) , whereas APC was physically disrupted in other mutations of APC components, such as cut4, cut9 and nuc2 (Yamashita et al., 1996; Yamada et al., 1997) . In addition, APC10/Doc1 has not been identi®ed in vertebrate APC.
In spite of the rapid progress on the studies of regulation of APC activity, whole APC core components and their precise subcellular localization during mitosis remains obscure. We therefore isolated and characterized human APC10/Doc1, and found that human APC10/Doc1 is one of the APC core components.
Results

Isolation of human APC10/Doc1 cDNA
A homology search of the human expressed sequence tag (EST) data base identi®ed a cDNA fragment that is signi®cantly homologous to APC10/Doc1 of budding yeast and ®ssion yeast (Irniger et al., 1995; Hwang and Murray, 1997; Kominami et al., 1998) . Full-length human APC10/Doc1 cDNA (DDBJ/EMBL/GenBank accession number AB012109) was isolated from a cDNA library of human erythroleukemia K562 cells, using an EST fragment ampli®ed by PCR as a probe. Sequence analysis of seven independent clones revealed that all cDNAs isolated encode the same open reading frame but have various amino-terminal sequences. Thus the translational initiation site was con®rmed by cap site PCR. Figure 1 shows the con®rmed fulllength human APC10/Doc1 sequence aligned with those of budding yeast and ®ssion yeast. Human APC10/Doc1 cDNA encodes a peptide of 185 amino acids with a predicted molecular mass of 21 252 daltons and a predicted isoelectric point of 9.71. Human APC10/Doc1 shares 28.5% and 37.8% amino acid sequence identity and 40.0% and 48.2% sequence similarity with those of budding yeast and ®ssion yeast, respectively.
Expression of human APC10/Doc1 during cell cycle
A polyclonal rabbit antiserum was raised against human APC10/Doc1 fused to glutathione S-transferase, and puri®ed by anity chromatography of the fusion protein. The puri®ed antibody detected APC10/ Doc1 of 24 kDa in HeLa cell lysates in G1/S phase and M phase ( Figure 2a) .
The expression level of APC10/Doc1 during the cell cycle was examined by immunoblot analysis. HeLa cells were arrested at G1/S phase by aphidicolin, released, and then re-arrested by nocodazole at prometaphase. The cells were harvested at various time points after nocodazole release, and the cell extracts were probed with anti-APC10/Doc1 antibody, anti-cyclin B1 antibody and anti-APC3/Cdc27 antibody. The cyclin B1 was mostly degraded within 60 min after nocodazole release ( Figure 2b Furthermore, the cell extracts were prepared at various time points after nocodazole release, and the immunoprecipitates with anti-APC10/Doc1 antibody were probed with anti-APC3/Cdc27 antibody ( Figure  3b , upper panel) or anti-APC6/Cdc16 antibody ( Figure  3b , lower panel). The amounts of immunoprecipitated APC10/Doc1 at each time point were constant (data not shown), and no APC subunit was detected by nonimmune serum (Figure 3b , lane 1). It was found that both APC3/Cdc27 and APC6/Cdc16 were always associated with APC10/Doc1 through prometaphase to S phase (Figure 3b ). These results indicate that APC10/Doc1 may be one of the APC core components rather than a transiently associated regulatory factor.
Subcellular localization of APC10/Doc1
It has been described that two human APC components, APC3/Cdc27 and APC6/Cdc16 are colocalized in centrosomes at all stages of the cell cycle and in mitotic spindles during mitosis , whereas mouse APC1/Tsg24 is localized in centromeres . To determine the exact subcellular localization of APC10/Doc1 during the cell cycle, we performed indirect immunofluorescence microscopic analyses in HeLa cells during mitosis. In early prophase, APC10/Doc1 was localized in the duplicated centrosomes and mitotic spindles (data not shown). In prometaphase, besides two spindle poles and mitotic spindles, a number of paired APC10/Doc1 stainings on the chromosomes were clearly visible (Figure 4, lane 1) . Double stainings of the cells with anti-centromere antibody together with anti-APC10/Doc1 antibody revealed that these paired dots on the chromosomes were kinetochores of the sister chromatids ( Figure 5, lane 1) . In triple stainings (APC10/Doc1, centromere and DNA), the double dots in a centromere staining could be clearly seen ( Figure  5 , lane 1, bottom panel). In metaphase, APC10/Doc1 was localized in centrosomes and in kinetochores, while the kinetochore stainings became faint (Figure 4 , lane 2). In anaphase A, APC10/Doc1 was localized in the spindle midzone, centrosomes and spindles (Figure 4 , lane 3). In anaphase B, it was primarily in the spindle midzone, and the stainings of the spindles and spindle poles became much weaker (Figure 4, lane 4) . The kinetochores were only weakly stained during anaphase ( Figure 5, lane 2) . In telophase and cytokinesis, APC10/Doc1 was mainly localized in midbody (Figure 4, lane 5) . In addition to the speci®c localization to centrosomes, kinetochores and spindles, APC10/Doc1 was diusely distributed in the cytoplasm throughout the mitosis (Figure 4) , while it was detected nowhere in interphase (data not shown).
Discussion
It was reported that the majority, but not all (or any) of the APC10/Doc1 population co-sedimented at 20S APC in a sucrose gradient in budding (or ®ssion) yeast (Hwang and Murray, 1997; Kominami et al., 1998) . Further, Xenopus APC10 homologue was not detected in APC which was puri®ed by immunoprecipitation with anti-APC3/Cdc27 antibody (Peters et al., 1996) . These results suggested that Doc1/Apc10 might be a factor which transiently associates with APC in a cell cycle-or substrate-speci®c manner. In this study, however, we described that human APC10/Doc1 always binds to APC and its protein level was constant throughout the cell cycle. Further, we found that the APC immunopuri®ed with anti-APC10/Doc1 antibody included stoichiometric amounts of APC10/ Doc1 with APC core components in a silver stained gel (data not shown). In the case of Xenopus APC10/Doc1, it might not have been detected in SDS ± PAGE because of its small size. Therefore, we concluded that human APC10/Doc1 may be a core component of APC rather than a transiently associated regulatory factor. Highly conserved sequences of APC10/Doc1 of various species (from yeast to human) also support this notion, while we cannot completely exclude the possibility that APC10/Doc1 is a substoichiometric component of APC.
We have shown in this paper that the subcellular localization of human APC10/Doc1 dynamically changes during mitosis. APC10/Doc1 was localized in centrosomes and mitotic spindles throughout mitosis, while it was in kinetochores from prophase to anaphase, in midzone in anaphase, and midbody in telophase and cytokinesis. It has been reported that human CDC27Hs and CDC16Hs are co-localized to the centrosomes throughout the cell cycle, and to the mitotic spindles during mitosis . In contrast, APC1/Tsg24 was detected in centromeres from prophase to anaphase in Chinese hamster ovary CHO cells, while it was constitutively associated with centromeres in mouse Swiss-3T3 ®broblasts . We also con®rmed the subcellular localization of these APC subunits by the same antibodies (data not shown). Taken together, these results suggest the following notion. The APC on the motor proteins may move along mitotic spindles between centrosomes and centromeres, and locate at the sites where the target molecules and/or regulatory factors of APC exist at a certain time point. The APC in kinetochores may ubiquitinate Cut2/Pds1 at metaphase/anaphase transition, and one in midbody may ubiquitinate Cyclin B, Cdc20, Ase1 and Plk which are known to be degraded during anaphase, telophase and cytokinesis (Koepp et al., 1999; Morgan, 1999; Weinstein, 1997; Descombes and Nigg, 1998; Jiang et al., 1998) . Indeed, some of these substrates (or regulatory factors) have been described as being colocalized with APC at the right time point (Golsteyn et al., 1995; Weinstein, 1997; Jiang et al., 1998) .
The role of APC10/Doc1 in APC activity is not known, but we also found that the APC immunoprecipitated with anti-APC10/Doc1 antibody contained whole APC core components, but it could not function as the ubiquitination machinery of cyclin B due to the inhibition of APC activity by the antibody (data not shown). These results are also consistent with the previous reports that APC10/Doc1 is essential component in APC activity (Irniger et al., 1995; Hwang and Murray, 1997; Kominami et al., 1998) . Taken together, we concluded that APC10/Doc1 is one of the core subunits of APC which may be necessary for its activity.
Materials and methods
Cell culture and synchronization
HeLa cells were grown in Dulbecco's modi®ed Eagle's medium (Gibco±BRL) supplemented with 10% fetal bovine serum. For synchronization with a double aphidicolin block, exponentially growing cells were arrested in the presence of 1 mg/ml aphidicolin (Wako Chemicals) for 18 h, washed with phosphate-buered saline (PBS), and incubated in fresh medium without aphidicolin for 8 h. Cells were then incubated with 1 mg/ml aphidicolin for additional 18 h to block cells at the G1/S boundary. To arrest cells in mitosis, they were treated with 1 mg/ml aphidicolin for 20 h, washed with PBS twice, incubated with fresh medium for 5 h and then blocked with medium containing 12 ng/ml nocodazole (Janssen) for 8 h. Mitotic cells were mechanically shaken o from the culture¯asks and collected. For the nocodazoleblock and release experiment, the mitotic shaken-o cells were washed twice with PBS prewarmed at 378C, incubated in prewarmed fresh medium for 20 min to 10 h, and then harvested.
cDNA cloning and sequencing
A partial human cDNA fragment encoding an open reading frame with homology to budding yeast Doc1 (ScDOC1) was identi®ed from a search of the NCBI dbEST using the BLAST algorithm. An EST clone (clone 668857) that signi®cantly matched ScDOC1 was sequenced. The radiolabeled cDNA fragment was used for screening a lgt10 cDNA library of human erythroleukemia K562 cells (Clontech). The obtained full-length human APC10/Doc1 cDNAs were then sequenced. The 5' end sequence was con®rmed by the sequencing of the Cap Site cDNA (Nippon Gene).
Immunoprecipitation and immunoblotting
The GST-fused full-length APC10/Doc1 in pGEX-2T was expressed in XL1-Blue MRF' with 0.4 mM isopropyl b-Dthiogalactopyranoside and isolated by anity chromatography on glutathione-Sepharose (Pharmacia). The puri®ed GST fusion protein was used to immunize a rabbit. The anti-APC10/Doc1 rabbit serum was anity-puri®ed with GST-APC10/Doc1 fusion protein coupled to HiTrap NHSactivated column (Pharmacia). Cells were washed with PBS twice and lysed with a lysis buer (50 mM Tris-HCl, pH 7.5, 0.5% NP-40, 150 mM NaCl, 2 mM sodium orthovanadate, 100 mM sodium¯uoride, 1 mM sodium pyrophosphate, 4 mM EDTA) including protease inhibitors (40 mM Pefablock, 1 mg/ml pepstatin A, 10 mg/ml leupeptin, 1 mg/ml aprotinin) and 100 nM microcystine LR at 48C for 30 min. The lysates were precleared with Protein ASepharose beads and used for immunoprecipitations. Antibodies were covalently coupled to Protein A beads as described (Harlow and Lane, 1998) . Ten ml of anti-APC10/ Doc1 antibody or anti-APC3/Cdc27 antibody beads were incubated with 250 mg of HeLa cell lysates at 48C for 3 h. The proteins were resolved by SDS ± PAGE, and transferred to nitrocellulose membrane. The membrane was blocked in 5% BSA or 5% skim milk in TBS (20 mM Tris-HCl, pH 7.6, 137 mM NaCl) for 8 h, washed with TBS-T (TBS with 0.5% Tween-20), and incubated either with anity puri®ed rabbit anti-APC10/Doc1 antibody (4 mg/ ml), rabbit anti-APC3/Cdc27 antiserum (1 : 6000 dilution), rabbit anti-APC6/Cdc16 antiserum (1 : 800 dilution), or mouse anti-human cyclin B1 antibody (Upstate Biotechnology) (1 : 2000 dilution) in TBS-T for 2 h at room temperature. The membrane was then washed four times with TBS-T, incubated with HRP-conjugated antirabbit and anti-mouse antibodies (Jackson ImmunoResearch Laboratories) for 1 h in TBS-T, washed three times with TBS-T, and then developed by enhanced chemiluminescence detection (Amersham).
Immunostaining
HeLa cells on coverslips were rinsed twice at room temperature with PHEM (60 mM PIPES, 25 mM HEPES, pH 6.9 with KOH, 10 mM EGTA, 2 mM MgCl 2 ) and lysed with 0.5% Triton X-100 in PHEM for 1 min at room temperature. The cells on coverslips were ®xed with cold (7208C) methanol for 5 min, immediately dried, and washed brie¯y with PBS. The coverslips were incubated in primary antibodies in an antibody solution (0.1 M PIPES ± KOH, pH 7.2, 1 mM MgSO 4 , 1 mM EGTA, 1.83% L-lysine, 1% BSA, 0.1% NaN 3 ) for 45 min at 378C. Primary antibodies used were: rabbit anti-APC10/Doc1 antiserum (1 : 200 dilution), human anti-centromere autoimmune serum (1 : 100 dilution) (Nagata et al., 1997) , or rat anti-tubulin antibody (Biosys) (1 : 20 dilution). After the wash with PBS, the coverslips were incubated with Cy3-conjugated anti-rabbit antibody (Jackson ImmunoResearch Laboratories) (1 : 250 dilution), and¯uorescein isothiocyanate-conjugated anti-rat antibody (Jackson ImmunoResearch Laboratories) (1 : 50 dilution) or anti-human antibody (Jackson ImmunoResearch Laboratories) (1 : 50 dilution) in antibody solution containing 1 mg/ml 4,6-diamidino-2-phenylindole (DAPI) for 45 min at 378C, washed with PBS, and mounted on slides with 90% glycerol, and 10% 106PBS containing para-phenylenediamine. Samples were observed using an Olympus¯uorescence microscope (BX60) and photographed.
Note added in proof
The accession number of human APC10/Doc1 is ABO12109. Grossberger et al. (1999) also reported the characterization of APC10/Doc1.
